BREAKING
Protagonist Therapeutics Jumps 7.0% in Broad Rally 9 hours ago Valaris Limited Drops 6.7% in Broad Selloff 11 hours ago Talos Energy Inc. Drops 6.2% Amid Sector-Wide Selling 11 hours ago Northern Oil and Gas, Inc. Drops 5.2% in Broad Selloff 11 hours ago Bank7 Corp. Tops Q1 Forecasts With $1.25 EPS, 20.2% Above Consensus 11 hours ago JetBlue Airways Corporation Surges 15.1% in Broad Rally 12 hours ago Celanese Corporation Shares Dropping 5.5% 12 hours ago Akamai Technologies, Inc. Shares Dropping 5.3% 12 hours ago Amazon.com, Inc. (AMZN) Jumps 5.2% to $232.68 12 hours ago Boot Barn Holdings, Inc. Shares Jumping 5.2% 12 hours ago Protagonist Therapeutics Jumps 7.0% in Broad Rally 9 hours ago Valaris Limited Drops 6.7% in Broad Selloff 11 hours ago Talos Energy Inc. Drops 6.2% Amid Sector-Wide Selling 11 hours ago Northern Oil and Gas, Inc. Drops 5.2% in Broad Selloff 11 hours ago Bank7 Corp. Tops Q1 Forecasts With $1.25 EPS, 20.2% Above Consensus 11 hours ago JetBlue Airways Corporation Surges 15.1% in Broad Rally 12 hours ago Celanese Corporation Shares Dropping 5.5% 12 hours ago Akamai Technologies, Inc. Shares Dropping 5.3% 12 hours ago Amazon.com, Inc. (AMZN) Jumps 5.2% to $232.68 12 hours ago Boot Barn Holdings, Inc. Shares Jumping 5.2% 12 hours ago
ADVERTISEMENT

Crawford & Company (CRD-A) Earnings: 3Q22 Key Numbers

Crawford & Company (NYSE: CRD-A) reported revenues before reimbursements of $294.9 million for the third quarter of 2022, up 2% year-over-year. Net loss attributable to shareholders was $15.1 million, or $0.31 per share, compared to net income of $11.2 million, or $0.20 per share, last year. Adjusted EPS was $0.16. Consolidated cash and cash equivalents […]

November 8, 2022 1 min read

Crawford & Company (NYSE: CRD-A) reported revenues before reimbursements of $294.9 million for the third quarter of 2022, up 2% year-over-year. Net loss attributable to shareholders was $15.1 million, or $0.31 per share, compared to net income of $11.2 million, or $0.20 per share, last year. Adjusted EPS was $0.16. Consolidated cash and cash equivalents […]

Crawford & Company (NYSE: CRD-A) reported revenues before reimbursements of $294.9 million for the third quarter of 2022, up 2% year-over-year.

Net loss attributable to shareholders was $15.1 million, or $0.31 per share, compared to net income of $11.2 million, or $0.20 per share, last year. Adjusted EPS was $0.16.

Consolidated cash and cash equivalents as of September 30, 2022, were $33.1 million.

ADVERTISEMENT